Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.46 USD | -1.63% |
|
+10.95% | +98.26% |
06-20 | Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing | MT |
06-18 | HC Wainwright Raises Price Target on Nurix Therapeutics to $26 From $19, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+98.26% | 1.34B | |
+16.49% | 122B | |
+21.73% | 116B | |
+22.18% | 27.03B | |
-21.81% | 20.36B | |
-16.89% | 16.43B | |
-18.81% | 15.91B | |
-44.74% | 15.6B | |
+62.72% | 14.94B | |
+3.09% | 13.59B |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- JPMorgan Adjusts Price Target on Nurix Therapeutics to $31 From $30, Maintains Overweight Rating